Literature DB >> 20980827

The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts.

Olga Aprelikova1, Xiang Yu, John Palla, Bih-Rong Wei, Simone John, Ming Yi, Robert Stephens, R Mark Simpson, John I Risinger, Amir Jazaeri, John Niederhuber.   

Abstract

It is well established that there is a dynamic relationship between the expanding tumor and the host surrounding tissue. Cancer-associated fibroblasts (CAFs), the most common cellular population found in the tumor microenvironment, supporting tumor growth and dissemination. Here, we set out to determine the factors that may be involved in dramatic alteration of gene expression pattern in CAFs, focusing on microRNA and transcriptional regulators. We established matched pairs of human CAFs isolated from endometrial cancer and normal endometrial fibroblasts. MicroRNA and mRNA analyses identified differential expression of 11 microRNAs, with miR-31 being the most downregulated microRNA in CAFs (p = 0.007). We examined several putative miR-31 target genes identified by microarray analysis and demonstrated that miR-31 directly targets the homeobox gene SATB2, which is responsible for chromatin remodeling and regulation of gene expression, and was significantly elevated in CAFs. The functional relevance of miR-31 and SATB2 were tested in in vitro models of endometrial cancer. Overexpression of miR-31 significantly impaired the ability of CAFs to stimulate tumor cell migration and invasion, without affecting tumor cell proliferation. Genetic manipulation of SATB2 levels in normal fibroblasts or CAFs showed that, reciprocally to miR-31, SATB2 increased tumor cell migration and invasion, while knockdown of endogenous SATB2 in CAFs reversed this phenotype. Introduction of SATB2 into normal fibroblasts stimulated expression of a number of genes involved in cell invasion, migration and scattering. These findings provide new insights into tumor-stroma interaction and document that miR-31 and its target gene SATB2, are involved in regulation of tumor cell motility.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980827      PMCID: PMC3055190          DOI: 10.4161/cc.9.21.13674

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  54 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Alpha-smooth muscle actin-positive myofibroblasts in endometrial stroma are not a reliable criterion for the diagnosis of well differentiated endometrioid adenocarcinoma in small tissue samples.

Authors:  B Czernobilsky; G Gabbiani; D Prus; B Lifschitz-Mercer
Journal:  Int J Gynecol Pathol       Date:  2001-07       Impact factor: 2.762

Review 3.  The role of the microenvironment in mammary gland development and cancer.

Authors:  Kornelia Polyak; Raghu Kalluri
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-30       Impact factor: 10.005

4.  The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism.

Authors:  Stephanos Pavlides; Aristotelis Tsirigos; Gemma Migneco; Diana Whitaker-Menezes; Barbara Chiavarina; Neal Flomenberg; Philippe G Frank; Mathew C Casimiro; Chenguang Wang; Richard G Pestell; Ubaldo E Martinez-Outschoorn; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2010-09-01       Impact factor: 4.534

5.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.

Authors:  F Moinfar; Y G Man; L Arnould; G L Bratthauer; M Ratschek; F A Tavassoli
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

6.  Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.

Authors:  Junming Guo; Ying Miao; Bingxiu Xiao; Rong Huan; Zhen Jiang; Dan Meng; Yanjun Wang
Journal:  J Gastroenterol Hepatol       Date:  2008-11-03       Impact factor: 4.029

7.  Over- and under-expressed microRNAs in human colorectal cancer.

Authors:  Kazuo Motoyama; Hiroshi Inoue; Yasushi Takatsuno; Fumiaki Tanaka; Koshi Mimori; Hiroyuki Uetake; Kenichi Sugihara; Masaki Mori
Journal:  Int J Oncol       Date:  2009-04       Impact factor: 5.650

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

9.  MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.

Authors:  Srinivas Veerla; David Lindgren; Anders Kvist; Attila Frigyesi; Johan Staaf; Helena Persson; Fredrik Liedberg; Gunilla Chebil; Sigurdur Gudjonsson; Ake Borg; Wiking Månsson; Carlos Rovira; Mattias Höglund
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

10.  Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer.

Authors:  Chao-Jie Wang; Zong-Guang Zhou; Ling Wang; Lie Yang; Bin Zhou; Jun Gu; Hong-Ying Chen; Xiao-Feng Sun
Journal:  Dis Markers       Date:  2009       Impact factor: 3.434

View more
  73 in total

1.  The RP-p53-Mdm2 pathway: a new link to genetic integrity?

Authors:  Rebeca A Frum; Yanping Zhang
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

Review 2.  Tracking miRNAs' footprints in tumor-microenvironment interactions: Insights and implications for targeted cancer therapy.

Authors:  Nazila Nouraee; Seyed Javad Mowla; George A Calin
Journal:  Genes Chromosomes Cancer       Date:  2015-03-31       Impact factor: 5.006

3.  Homeobox Gene Deregulation: Impact on the Hallmarks of Cancer.

Authors:  Dhwani Haria; Honami Naora
Journal:  Cancer Hallm       Date:  2013-09-01

4.  RB in breast cancer: differential effects in estrogen receptor-positive and estrogen receptor-negative disease.

Authors:  Elizabeth A Musgrove; Robert L Sutherland
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

Review 5.  MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment.

Authors:  F J Kohlhapp; A K Mitra; E Lengyel; M E Peter
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

Review 6.  Stromal cells in tumor microenvironment and breast cancer.

Authors:  Yan Mao; Evan T Keller; David H Garfield; Kunwei Shen; Jianhua Wang
Journal:  Cancer Metastasis Rev       Date:  2013-06       Impact factor: 9.264

7.  Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.

Authors:  Ling Li; Klaus Piontek; Masaharu Ishida; Michel Fausther; Jonathan A Dranoff; Rongdang Fu; Esteban Mezey; Stephen J Gould; Francis K Fordjour; Stephen J Meltzer; Alphonse E Sirica; Florin M Selaru
Journal:  Hepatology       Date:  2016-08-29       Impact factor: 17.425

8.  Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer.

Authors:  Xin Min Xu; Jian Chang Qian; Zhou Lu Deng; Zhe Cai; Tao Tang; Peng Wang; Ke Hua Zhang; Jian-Ping Cai
Journal:  Oncol Lett       Date:  2012-05-14       Impact factor: 2.967

9.  MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells.

Authors:  Zhiwei Zhong; Zhuo Dong; Lihua Yang; Xiaoqiang Chen; Zhaohui Gong
Journal:  Tumour Biol       Date:  2013-03-29

Review 10.  Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

Authors:  Naofumi Mukaida; Soichiro Sasaki
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.